121 related articles for article (PubMed ID: 10560994)
21. [Effects of tibolone on lipid and glucose metabolism as well as insulin secretion in postmenopausal women].
Villanueva LA; Ortega R; Morimoto S; Villanueva S; Arranz C
Ginecol Obstet Mex; 1999 Oct; 67():473-7. PubMed ID: 10582394
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of tibolone and estrogen therapy on hemostasis in surgical menopause: a randomized, double-blind, placebo-controlled study.
Demirol A; Guven S; Guvendag Guven ES; Kirazli S; Gurgan T; Ayhan A
Fertil Steril; 2007 Apr; 87(4):842-8. PubMed ID: 17222829
[TBL] [Abstract][Full Text] [Related]
23. Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK.
Plumb JM; Guest JF
Pharmacoeconomics; 2000 Nov; 18(5):477-86. PubMed ID: 11151401
[TBL] [Abstract][Full Text] [Related]
24. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
Lundström E; Christow A; Kersemaekers W; Svane G; Azavedo E; Söderqvist G; Mol-Arts M; Barkfeldt J; von Schoultz B
Am J Obstet Gynecol; 2002 Apr; 186(4):717-22. PubMed ID: 11967497
[TBL] [Abstract][Full Text] [Related]
25. Short and long term effects of tibolone in postmenopausal women.
Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
Morris EP; Rymer J; Robinson J; Fogelman I
Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
[TBL] [Abstract][Full Text] [Related]
27. Auditory evoked responses in postmenopausal women on hormone replacement therapy.
Khaliq F; Tandon OP; Goel N
Indian J Physiol Pharmacol; 2003 Oct; 47(4):393-9. PubMed ID: 15266950
[TBL] [Abstract][Full Text] [Related]
28. Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Am J Obstet Gynecol; 2000 Sep; 183(3):575-82. PubMed ID: 10992176
[TBL] [Abstract][Full Text] [Related]
29. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
Lundström E; Hirschberg AL; Söderqvist G
Maturitas; 2011 Dec; 70(4):361-4. PubMed ID: 21958943
[TBL] [Abstract][Full Text] [Related]
30. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
[TBL] [Abstract][Full Text] [Related]
31. Effect of tibolone administration on heart rate variability and free fatty acid levels in postmenopausal women.
Manzella D; Fornaro F; Carbonella M; Picardi C; Paolisso G; Colacurci N
Fertil Steril; 2002 Nov; 78(5):1005-9. PubMed ID: 12413985
[TBL] [Abstract][Full Text] [Related]
32. Muscle strength and tibolone: a randomised, double-blind, placebo-controlled trial.
Meeuwsen IB; Samson MM; Duursma SA; Verhaar HJ
BJOG; 2002 Jan; 109(1):77-84. PubMed ID: 11845814
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women.
Cicinelli E; Ranieri G; Maffei S; Colafiglio G; Ria R; Bellavia M; Schonauer MM
Fertil Steril; 2006 Oct; 86(4):899-904. PubMed ID: 16963035
[TBL] [Abstract][Full Text] [Related]
34. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial.
Morais-Socorro M; Cavalcanti MA; Martins R; Neto Francisco P; Rezende A; Azevedo G; Almeida M
Gynecol Endocrinol; 2012 Jun; 28(6):483-7. PubMed ID: 22132809
[TBL] [Abstract][Full Text] [Related]
36. Effects of tibolone on abdominal subcutaneous fat, serum leptin levels, and anthropometric indices: a 6-month, prospective, randomized, placebo-controlled, double-blind study.
Odabasi AR; Yuksel H; Kafkas S; Demircan S; Karul A; Kozaci D; Koseoglu K; Onur E
Adv Ther; 2006; 23(6):926-37. PubMed ID: 17276962
[TBL] [Abstract][Full Text] [Related]
37. Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women.
Vitale C; Mammi C; Gambacciani M; Russo N; Spoletini I; Fini M; Volterrani M; Rosano GMC
Int J Cardiol; 2017 Jan; 227():217-221. PubMed ID: 27843051
[TBL] [Abstract][Full Text] [Related]
38. Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study.
Winkler UH; Altkemper R; Kwee B; Helmond FA; Coelingh Bennink HJ
Fertil Steril; 2000 Jul; 74(1):10-9. PubMed ID: 10899490
[TBL] [Abstract][Full Text] [Related]
39. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
Dedeoğlu EN; Erenus M; Yörük P
Fertil Steril; 2009 Feb; 91(2):425-31. PubMed ID: 18249383
[TBL] [Abstract][Full Text] [Related]
40. Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone.
Kulkarni J; Gavrilidis E; Thomas N; Hudaib AR; Worsley R; Thew C; Bleeker C; Gurvich C
J Affect Disord; 2018 Aug; 236():88-92. PubMed ID: 29723767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
